Inge C. Gyssens - Infectious Diseases

Author Information

Inge C. Gyssens is a prominent researcher in the field of Infectious Diseases, currently affiliated with Radboud University Medical Center in Nijmegen, the Netherlands. Her work also extends to the Department of Medical Microbiology and Infectious Diseases at Canisius-Wilhelmina Hospital, Nijmegen, and Hasselt University in Belgium. Her extensive research contributions have made significant impacts in the study and understanding of infectious diseases, particularly in the area of sepsis and antibiotic use.

Research Contributions

Inge C. Gyssens has made substantial contributions to the field of Infectious Diseases through her research on sepsis, antibiotic therapy, and infection control. Her recent studies include exploring inflammatory biomarkers for sepsis diagnosis, investigating the reactivation of herpes simplex virus in COVID-19 patients, and evaluating infection control measures in hospitals. Her work often focuses on practical applications, such as improving diagnostic and prognostic tools for sepsis and implementing effective infection control strategies in healthcare settings.

Aliases

Inge C. Gyssens is known by several aliases including Inge Gyssens, I. C. Gyssens, and I. Gyssens among others. These variations are often used interchangeably in her published works and academic contributions.

Publication and Citation Metrics

Metrics	Value
Total Papers	183
Total Citations	6914
h-index	43

Publications:

A prospective observational cohort study to identify inflammatory biomarkers for the diagnosis and prognosis of patients with sepsis

DOI: 10.1186/s40560-022-00602-x

Year: 2022

Implementation of the Infection Risk Scan (IRIS) in nine hospitals in the Belgian-Dutch border region (i-4-1-Health project)

DOI: 10.1186/s13756-022-01083-1

Year: 2022

Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study

DOI: 10.3390/microorganisms9091896

Year: 2021

Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes.

DOI: 10.1016/j.ijantimicag.2021.106379

Year: 2021

A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit

DOI: 10.1186/s13756-021-00990-z

Year: 2021

Risk Factors for Mortality, Intensive Care Unit Admission, and Bacteremia in Patients Suspected of Sepsis at the Emergency Department: A Prospective Cohort Study

DOI: 10.1093/ofid/ofaa594

Year: 2021

A case study on Staphylococcus aureus bacteraemia: available treatment options, antibiotic R&D and responsible antibiotic-use strategies

DOI: 10.1093/jacamr/dlaa034

Year: 2020

Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.

DOI: 10.1016/j.meegid.2020.104263

Year: 2020

An observational study of innate immune responses in patients with acute appendicitis

DOI: 10.1038/s41598-020-73798-3

Year: 2020

ATP measurement as an objective method to measure environmental contamination in 9 hospitals in the Dutch/Belgian border area

DOI: 10.1186/s13756-020-00730-9

Year: 2020

How Does Personalized Medicine Apply to Infectious Diseases?

What are Sporozoites?

Are There Metabolic Pathway Differences Between Pathogens and Hosts?

What is Proteomics?

Why is RT-PCR important in Infectious Diseases?

What are the Risk Factors for HAIs?

What are the Treatments for Zika Virus?

What is the Importance of Partner Notification?

How Do Pathogens Utilize Fatty Acid Biosynthesis?

What are the Risk Factors for Developing Dengue Hemorrhagic Fever?

Partnered Content Networks

Relevant Topics